Role of CFTR Arginine-933 in Channel Function and Potentiator Binding and Efficacy – Stephen Aller, PhD

Dr. Stephen Aller, Associate Professor at the Department of Pharmacology and Toxicology at the University of Alabama at Birmingham, presents results from CFRI-funded research on the role of CFTR Arginine-933 in folding, gating and potentiator drug binding. This presentation was part of CFRI's Virtual 35th National CF Education Conference on July 30, 2022.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.